目次

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation
1.1.1 Segment Definitions
1.1.1.1 Product Segment
1.1.1.2 Nutrient Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Gvr’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.9.1.1 Research Scope And Assumptions
1.10 List Of Secondary Sources
1.11 List Of Primary Sources
1.12 List Of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape

Chapter 3 Intravenous Solutions Market Variables And Trends
3.1 Intravenous Solutions Market Lineage Outlook
3.1.1 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Growing Number Of Premature Births
3.2.1.2 Increasing Incidence Of Cancer
3.2.1.3 Increasing Risk Of Malnutrition
3.2.1.4 Growing Geriatric Population
3.2.2 Market Restraint Analysis
3.2.2.1 Shortage Of Parenteral Nutrition Products
3.2.2.2 Increased Use Of Enteral Nutrition
3.2.2.3 High Risk Of Infections
3.3 Regulatory Framework
3.3.1 Standards And Compliances
3.3.1.1 North America
3.3.1.2 Europe
3.3.1.3 Apac
3.3.1.4 Latin America
3.3.1.5 MEA
3.3.2 Reimbursement Scenario
3.3.2.1 U.S.
3.3.2.2 Canada
3.3.2.3 Germany
3.3.2.4 Uk
3.3.2.5 Japan
3.3.2.6 Australia
3.3.2.7 China
3.4 Impact Of Covid-19 Pandemic
3.5 Industry Analysis Tools
3.5.1 Porter’s Analysis
3.5.2 Macroeconomic Analysis

Chapter 4 Intravenous Solutions Market: Product Analysis
4.1 Product Movement Analysis & Market Share, 2022 & 2030
4.2 Intravenous Solutions Market Estimates & Forecast, By Product (USD Million)
4.3 Total Parenteral Nutrition
4.3.1 Total Parenteral Nutrition Market, 2018 - 2030 (USD Million)
4.4 Peripheral Parenteral Nutrition
4.4.1 Peripheral Parenteral Nutrition Market, 2018 - 2030 (USD Million)

Chapter 5 Intravenous Solutions Market: Nutrients Analysis
5.1 Nutrients Movement Analysis & Market Share, 2022 & 2030
5.2 Intravenous Solutions Market Estimates & Forecast, By Nutrients (USD Million)
5.3 Carbohydrates
5.3.1 Carbohydrates Market, 2018 - 2030 (USD Million)
5.4 Single Dose Amino Acid Solution
5.4.1 Single Dose Amino Acid Solution Market, 2018 - 2030 (USD Million)
5.5 Vitamins & Minerals
5.5.1 Vitamins & Minerals, 2018 - 2030 (USD Million)
5.6 Parenteral Lipid Emulsion
5.6.1 Parenteral Lipid Emulsion, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others Market, 2018 - 2030 (USD Million)

Chapter 6 Intravenous Solutions Market: Regional Estimates & Trend Analysis
6.1 Intravenous Solutions Market: Regional Outlook
6.2 North America
6.2.1 North America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 Key Country Dynamics
6.2.2.2 U.S. Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Key Country Dynamics
6.2.3.2 Canada Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.2 Uk
6.3.2.1 Key Country Dynamics
6.3.2.2 Uk Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Key Country Dynamics
6.3.3.2 Germany Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.4 France
6.3.4.1 Key Country Dynamics
6.3.4.2 France Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Key Country Dynamics
6.3.5.2 Italy Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Key Country Dynamics
6.3.6.2 Spain Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.7 Denmark
6.3.7.1 Key Country Dynamics
6.3.7.2 Denmark Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.8 Sweden
6.3.8.1 Key Country Dynamics
6.3.8.2 Sweden Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.9 Norway
6.3.9.1 Key Country Dynamics
6.3.9.2 Norway Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Key Country Dynamics
6.4.2.2 Japan Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 Key Country Dynamics
6.4.3.2 China Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4 India
6.4.4.1 Key Country Dynamics
6.4.4.2 India Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.5 Australia
6.4.5.1 Key Country Dynamics
6.4.5.2 Australia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 Key Country Dynamics
6.4.6.2 South Korea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.7 Thailand
6.4.7.1 Key Country Dynamics
6.4.7.2 Thailand Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.2 Mexico
6.5.2.1 Key Country Dynamics
6.5.2.2 Mexico Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.3 Brazil
6.5.3.1 Key Country Dynamics
6.5.3.2 Brazil Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Key Country Dynamics
6.5.4.2 Argentina Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6 Middle East & Africa (MEA)
6.6.1 MEA Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 Key Country Dynamics
6.6.2.2 South Africa Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Key Country Dynamics
6.6.3.2 Saudi Arabia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 Key Country Dynamics
6.6.4.2 UAE Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.5 Kuwait
6.6.5.1 Key Country Dynamics
6.6.5.2 Kuwait Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis
7.1 Company Categorization
7.2 Participants’ Overview
7.3 Financial Performance
7.4 Product Benchmarking
7.5 Market Participant Categorization
7.5.1 Heat Map Analysis
7.6 Company Market Share Analysis, 2022
7.7 Strategy Mapping
7.7.1 Mergers & Acquisitions
7.7.2 Product Launch
7.7.3 Partnerships & Collaborations
7.7.4 Product Approvals
7.7.5 Expansion
7.7.6 Others

Chapter 8 Analyst Perspective

List of Figures
Fig. 1 Intravenous solutions market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape
Fig. 12 Intravenous solutions market dynamics
Fig. 13 Preterm birth rates in the U.S., 2011 to 2030
Fig. 14 Number of undernourished people in the world, 2015 - 2020 (Million and Percentage)
Fig. 15 Intravenous solutions market: PORTER’s analysis
Fig. 16 Intravenous solutions market: PESTEL analysis
Fig. 17 Intravenous solutions market: by product: key takeaways
Fig. 18 Intravenous solutions market, by product: market share, 2022 & 2030
Fig. 19 Total parenteral nutrition market, 2018 - 2030 (USD Million)
Fig. 20 Peripheral parenteral nutrition market, 2018 - 2030 (USD Million)
Fig. 21 Intravenous solutions market, by end-use: key takeaways
Fig. 22 Intravenous solutions market, by nutrients: market share, 2022 & 2030
Fig. 23 Carbohydrates market, 2018 - 2030 (USD Million)
Fig. 24 Single dose amino acid solution market, 2018 - 2030 (USD Million)
Fig. 25 Vitamins and minerals, 2018 - 2030 (USD Million)
Fig. 26 Parenteral lipid emulsion, 2018 - 2030 (USD Million)
Fig. 27 Others market, 2018 - 2030 (USD Million)
Fig. 28 Intravenous solutions market revenue, by region, 2022 & 2030 (USD Million)
Fig. 29 Regional marketplace: key takeaways
Fig. 30 Regional marketplace: key takeaways
Fig. 31 North America intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 32 Key country dynamics
Fig. 33 U.S. intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 34 Key country dynamics
Fig. 35 Canada intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 36 Europe intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
Fig. 38 UK intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 39 Key country dynamics
Fig. 40 Germany intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 41 Key country dynamics
Fig. 42 France intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 43 Key country dynamics
Fig. 44 Italy intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 45 Key country dynamics
Fig. 46 Spain intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 Denmark intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Sweden intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Norway intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 Japan intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 China intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 India intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 Australia intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 South Korea intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Thailand intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 66 Latin America intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Mexico intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Brazil intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Argentina intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 73 MEA intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 South Africa intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 Saudi Arabia intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 UAE intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Kuwait intravenous solutions market, 2018 - 2030 (USD Million)
Fig. 82 Key company categorization
Fig. 83 Heat map analysis
Fig. 84 Company market share analysis, 2022
Fig. 85 Strategy mapping